Real-life effectiveness of Golimumab in biologic-naïve patients with rheumatoid arthritis - data from the Rheumatic Diseases Portuguese Register (Reuma.pt)

Real-life effectiveness of Golimumab in biologic-naïve patients with rheumatoid arthritis - data from the Rheumatic Diseases Portuguese Register (Reuma.pt)

Objectives. To assess the effectiveness of subcutaneous Golimumab 50 mg/monthly combined with methotrexate (SC GLM + MTX) over 52 weeks of treatment, in biologic-naïve RA patients, in a multicentre nationwide cohort from the Rheumatic Diseases Portuguese Register (Reuma.pt). Methods. Data for this...

Full description

Bibliographic Details
Main Authors: Ana Filipa Mourão, Célia Ribeiro, Joana Borges, Maria João Gonçalves, Miguel Bernardes, Susana Fernandes, Raquel Dezerto, Pedro Laires, Patrícia Machado, Mónica Eusébio, Maria José Santos, Helena Canhão
Format: Article
Language:English
Published: Sociedade Portuguesa de Reumatologia 2017-04-01
Series:Acta Reumatológica Portuguesa
Subjects:
effectiveness
rheumatoid arthritis
Reuma.pt
golimumab
persistence
Online Access:http://www.actareumatologica.com/files/article/1168_real_life_effectiveness_of_golimumab_in_biologic_na_ve_patients_with_rheumatoid_arthritis_data_from_the_rheumatic_diseases_portuguese_register_reuma_pt_file.pdf

Internet

http://www.actareumatologica.com/files/article/1168_real_life_effectiveness_of_golimumab_in_biologic_na_ve_patients_with_rheumatoid_arthritis_data_from_the_rheumatic_diseases_portuguese_register_reuma_pt_file.pdf

Similar Items